Study of Methylation Levels of Parkin Gene Promoter in Parkinson's Disease Patients
Authors:
- Jun TianJTJun Tian
- Guo-Hua ZhaoGZGuo-Hua Zhao
- Wei LuoWLWei Luo
- Bao-Rong ZhangBZBao-Rong Zhang
- 10 June 2011
- journal article
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 121 (9) , 497-502
Abstract
Mutations in the parkin gene have been significantly linked to autosomal recessive juvenile parkinsonism (ARJP). In addition to its association with ARJP, loss of heterozygosity of parkin has been found in several types of malignant tumors, including ovarian, breast, and hepatocellular tumors. Abnormal methylation of parkin promoter was observed in patients with acute lymphoblastic leukemia and chronic myelogenous leukemia in lymphoid blast crisis. We hypothesized that hypermethylation of the parkin promoter might reduce the expression of parkin, which would contribute to the pathogenesis of parkinson's disease (PD) in idiopathic patients and parkin heterozygotes. In this study, we analyzed samples from 17 PD patients with heterozygous parkin mutations, 17 PD patients without parkin mutations, and 10 normal controls. We determined the levels of methylation of the parkin gene promoter in each group using bisulfite genomic sequencing of a region containing 33 CpG sites in the CpG island of the parkin promoter. The methylation levels indicated hypomethylation, and there were no significant differences in the incidence of CpG site methylation among three groups (P > 0.05). These results suggest that the methylation mechanism is unlikely to play a role in the pathogenesis and development of PD.Keywords
This publication has 22 references indexed in Scilit:
- Genetics of Parkinson’s disease and parkinsonismExpert Review of Neurotherapeutics, 2007
- Case-Control Study of the Parkin Gene in Early-Onset Parkinson DiseaseArchives of Neurology, 2006
- Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemiaInternational Journal of Cancer, 2005
- Alterations in the common fragile site gene Parkin in ovarian and other cancersOncogene, 2003
- Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancerGenes, Chromosomes and Cancer, 2003
- Parkin , a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25–q27Proceedings of the National Academy of Sciences, 2003
- CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter futureOncogene, 2002
- The Genomic Structure and Promoter Region of the Human Parkin GeneBiochemical and Biophysical Research Communications, 2001
- Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1997
- CpG Islands in vertebrate genomesJournal of Molecular Biology, 1987